Solbiati José, Cronan John E
Department of Microbiology, University of Illinois, Urbana, IL 61801, USA.
Chem Biol. 2010 Jan 29;17(1):11-7. doi: 10.1016/j.chembiol.2009.12.007.
Transcription of the Escherichia coli biotin (bio) operon is regulated by BirA, a protein that is not only the repressor that regulates bio operon expression by DNA binding but also the enzyme that covalently attaches biotin to its cognate acceptor proteins. Binding of BirA to the bio operator requires dimerization of the protein that is triggered by BirA-catalyzed synthesis of biotinoyl-adenylate (bio-AMP), the obligatory intermediate of the attachment reaction. The current model postulates that the unmodified acceptor protein binds the monomeric BirA:bio-AMP complex and thereby blocks assembly (dimerization) of the form of BirA that binds DNA. We report that expression of fusion proteins that carry synthetic biotin-accepting peptide sequences was as effective as the natural acceptor protein in derepression of bio operon transcription. These peptide sequences have sequences that are remarkably dissimilar to that of the natural acceptor protein, and our data thus argue that the regulatory switch does not require the extensive protein-protein interactions postulated in the current model.
大肠杆菌生物素(bio)操纵子的转录受BirA调控,BirA这种蛋白质不仅是通过结合DNA来调节bio操纵子表达的阻遏物,还是将生物素共价连接到其同源受体蛋白的酶。BirA与bio操纵基因的结合需要该蛋白质二聚化,而这是由BirA催化合成生物素酰腺苷酸(bio-AMP)引发的,bio-AMP是连接反应的必需中间体。当前模型假定未修饰的受体蛋白结合单体BirA:bio-AMP复合物,从而阻止能结合DNA的BirA形式的组装(二聚化)。我们报道,携带合成生物素接受肽序列的融合蛋白的表达在解除bio操纵子转录抑制方面与天然受体蛋白一样有效。这些肽序列与天然受体蛋白的序列明显不同,因此我们的数据表明,这种调节开关并不需要当前模型中假定的广泛的蛋白质-蛋白质相互作用。